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Otilonium bromide (OB) is a quaternary ammonium derivative successfully used 
for the treatment of irritable bowel syndrome (IBS). Several in vitro experiments 
in human and rat colon demonstrated its spasmolytic capability due to the block of 
muscarinic and tachykinin receptors and L-type Ca2+ channels. Moreover, in vivo 
OB administrations showed interesting interaction with the enteric nervous system in 
healthy rats (1). The wrap restrain stress (WRS) is considered an adequate model of 
psychosocial stressor, able to induce most of the IBS signs and symptoms. WRS leads 
to important changes in the enteric neurotransmitters of rat colon, as recently demon-
strated (2). Consequently, we chose this animal model to investigate whether a repeat-
ed, oral treatment with OB prevented the functional and neurotransmitters’ changes 
reported in rats underwent to WRS. The results obtained by using multiple experi-
mental approaches (in vivo colonic functional evaluations, routine histology, immu-
nohistochemistry and western blot) showed that OB is able to counteract most of the 
morphological changes caused by WRS in the colonic wall. In particular, the drug pre-
vents the decrease in SP-, NK1r-, nNOS-, VIP- and S100β-immunoreactivity (IR) and 
the increase in CGRP- and CRF1r-IR detected in WRS rats. On the contrary, OB does 
not interfere with the mild mucosal inflammation and does not affect the increase in 
CRF2r-immunoreactive neurons observed in WRS rats. Moreover, OB per se increases 
the muscarinic receptor 2 expression in the muscle wall and decreases the number of 
the myenteric ChAT-immunoreactive neurons. Functional findings show a significant-
ly reduction in the number of spontaneous abdominal contraction in OB treated rats. 
The ability of OB to block L-type Ca2+ channels, also expressed by enteric neurons, 
might explain the drug efficacy in preventing excessive neuronal response to stress. 
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